白物质超强度在行为变体前性痴呆症和语义变体初级渐进性失言症中
Rafi Hadad1,2, Yann Cobigo3, Andjelika Milicic2,3
1Stroke and Cognition Institute, Department of Neurology, Rambam Health Care Campus, Haifa, Israel.
Neurology open access
|March 9, 2026
概括
白质超强度 (WMH) 在行为变异前性痴呆症 (bvFTD) 和语义变异初级渐进性失语症 (svPPA) 患者中升高,独立于脑血管风险因素. 这些变化表明非血管机制有助于这些FTD亚型的WMH.
科学领域:
- 神经成像是一种神经成像.
- 神经学 神经学
- 神经退行发生神经退行.
背景情况:
- 白质过强度 (WMH) 与脑血管风险因素 (CVRF) 和神经退行性疾病 (如前叶退行症 (FTLD)) 有关.
- 此外,WMH也可能与影响白质或FTLD的遗传变异有关.
- 了解特定FTD亚型中的WMH负担对于诊断和了解疾病机制至关重要.
研究的目的:
- 调查WMH的负担和空间分布,在患者的行为变体前性痴呆 (bvFTD) 和语义变体初级渐进性失语症 (svPPA).
- 为了比较bvFTD和svPPA患者的WMH负担与年龄和性别匹配的对照.
- 评估脑血管风险因素 (CVRF) 在这些患者群体中对WMH的影响.
主要方法:
- 从bvFTD,svPPA患者和对照组的结构性MRI数据的横截面回顾分析.
- 使用标准化成像分析来评估WMH负担和空间分布.
- 进行了统计分析,以比较群体并评估与CVRF和遗传因素的关联,根据年龄,APOE-ε4状态和内体积进行调整.
主要成果:
- 与CVRF独立的对照组相比,bvFTD和svPPA组的WMH负担显著更高.
- bvFTD患者在额叶中表现出普遍存在的WMH.
- svPPA患者表现出更广泛的WMH分布在额叶,额叶,叶,叶,叶和体.
结论:
- bvFTD和svPPA与增加的WMH负担有关,这表明非血管潜在机制.
- 在bvFTD和svPPA中WMH的独特空间模式可能反映了亚型特定的神经退行过程.
- 需要对更大,多中心的队列进行进一步的研究,以探索遗传关联并确认发现.
相关概念视频
01:30Dementia
633
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
633
01:26Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
03:03Amyloid Fibrils
12.4K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.4K